COVID-19 vaccination.

As the new coronavirus continues to spread around the world, the vaccine is seen as the best way to stop it. Everyone above 18 years of age will be eligible to get vaccinated against COVID-19 from May 1. Anyone who has an allergy to any component of the vaccine, should not take it. While COVID-19 vaccine supplies are limited, health workers at high risk of exposure and older people should be prioritized for vaccination.

Covaxin is an inactivated vaccine which means that it is made up of killed coronaviruses, making it safe to be injected into the body.Bharat Biotech, a 24-year-old vaccine maker with a portfolio of 16 vaccines and exports to 123 countries, used a sample of the coronavirus, isolated by India’s National Institute of Virology.The two doses are given four weeks apart. The vaccine can be stored at 2C to 8C.Some mild symptoms AEFIs may occur like injection site pain, headache, fatigue, fever, body ache, abdominal pain, nausea and vomiting, dizziness-giddiness, tremor, sweating, cold, cough and injection site swelling. No other vaccine-related serious adverse effects have been reported.It is your choice to receive or not receive COVAXIN . other vaccines. If you are pregnant or breastfeeding, you should not get the vaccine as the effect of the vaccine has not been studied in pregnant women and nursing mothers.

Covishild is a recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike (S) glycoprotein. Following administration, the genetic material of part of corona virus is expressed which stimulates an immune response.People aged 65 and older are less likely to experience common side effects.

More than 1 in 10 people may experience:

feeling tired
tenderness, bruising, pain or itching in the arm where you had the vaccine injection
headache
muscle pain
joint pain
nausea
fever (temperature of 38 degrees Celsius or above)

Sputnik V Covid-19 Vaccine: Sputnik V is a two-dose Covid-19 vaccine, which has an efficacy of over 91 per cent, according to a publication in scientific journal The Lancet.Made by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow, Sputnik V is a two-dose Covid-19 vaccine using a similar platform to Covishield — the most widely used vaccine in India since the government’s immunisation programme began in January. So far, DRL has only received 150,000 doses of this vaccine from Russia. The company expects more doses soon. According to its agreement with the Russian Direct Investment Fund (RDIF), which has been in charge of signing agreements for supply of this vaccine across the world, India is expected to get at least 250 million doses, which will be sufficient to inoculate 125 million people. However, it is unclear by when these doses will be supplied and distributed in India.The imported vaccine has been priced at Rs 948 per dose. However, including 5 per cent Goods and Services Tax, the price of this vaccine goes up to Rs 995.40 per dose.the most common side effects were: flu-likeillness, headache, fatigue, injection-site reactions.

Categories: Health, News

Tagged as: , , ,